Largest market shown
Egypt
$535.4M calculated opportunity across 7 screened products.
Regional export playbook
Compare buyer markets, access conditions, and product opportunities across Africa. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Africa regional view
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Largest market shown
$535.4M calculated opportunity across 7 screened products.
Regional footprint
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| EgyptEGY | $535.4M | 7 | Not reported | 0 km | 0 | Tricycles, scooters, pedal cars and similar wheeled toys: dolls' carriages: dolls: other toys: reduced-size (scale) models and similar recreational models, working or not: puzzles of all kinds |
| AlgeriaDZA | $286.8M | 4 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| MoroccoMAR | $250.0M | 3 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| United Rep. of TanzaniaTZA | $158.6M | 1 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| Côte d\'IvoireCIV | $154.2M | 1 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| EthiopiaETH | $142.4M | 1 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| South AfricaZAF | $131.3M | 1 | Not reported | 0 km | 0 | Plastics: other articles n.e.s. in chapter 39 |
| TunisiaTUN | $88.8M | 1 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| AngolaAGO | $57.3M | 1 | Not reported | 0 km | 0 | Motorcycles (including mopeds) and cycles: fitted with an auxiliary motor, reciprocating internal combustion piston engine, of cylinder capacity exceeding 50cc but not exceeding 250cc, with or without side-cars: side-cars |
| MauritaniaMRT | $29.6M | 1 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
Top regional opportunities
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | United Rep. of TanzaniaTZA | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $158.6M | +8.8% | +0.0% |
| 2 | Côte d\'IvoireCIV | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $154.2M | +3.3% | +0.0% |
| 3 | AlgeriaDZA | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $147.3M | +1.2% | +0.3% |
| 4 | EthiopiaETH | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $142.4M | +12.1% | +0.0% |
| 5 | EgyptEGY | HS 950300Tricycles, scooters, pedal cars and similar wheeled toys: dolls' carriages: dolls: other toys: reduced-size (scale) models and similar recreational models, working or not: puzzles of all kinds | $138.1M | +5.5% | +0.0% |
| 6 | South AfricaZAF | HS 392690Plastics: other articles n.e.s. in chapter 39 | $131.3M | +8.3% | +0.0% |
| 7 | MoroccoMAR | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $120.6M | +8.4% | +0.0% |
| 8 | MoroccoMAR | HS 080410Fruit, edible: dates, fresh or dried | $97.9M | +20.7% | +0.1% |
| 9 | TunisiaTUN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $88.8M | +3.1% | +0.0% |
| 10 | EgyptEGY | HS 392690Plastics: other articles n.e.s. in chapter 39 | $83.8M | +7.7% | +0.0% |
| 11 | EgyptEGY | HS 391990Plastics: plates, sheets, film, foil, tape, strip, other flat shapes thereof, self-adhesive, other than in rolls of a width not exceeding 20cm | $79.9M | +9.7% | +0.0% |
| 12 | AlgeriaDZA | HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $74.8M | +13.0% | +4.9% |
| 13 | EgyptEGY | HS 870899Vehicle parts and accessories: n.e.c. in heading no. 8708 | $70.5M | +1.7% | +0.0% |
| 14 | EgyptEGY | HS 520942Fabrics, woven: containing 85% or more by weight of cotton, of yarns of different colours, weighing more than 200g/m2, denim | $67.1M | +8.4% | +0.0% |
| 15 | AngolaAGO | HS 871120Motorcycles (including mopeds) and cycles: fitted with an auxiliary motor, reciprocating internal combustion piston engine, of cylinder capacity exceeding 50cc but not exceeding 250cc, with or without side-cars: side-cars | $57.3M | +15.2% | +0.0% |
| 16 | EgyptEGY | HS 732690Iron or steel: articles n.e.s. in heading no. 7326 | $49.2M | +7.2% | +0.0% |
| 17 | EgyptEGY | HS 150910Vegetable oils: olive oil and its fractions, virgin, whether or not refined, but not chemically modified | $46.8M | +18.9% | +0.0% |
| 18 | AlgeriaDZA | HS 294190Antibiotics: n.e.c. in heading no. 2941 | $33.0M | +11.5% | +0.0% |
| 19 | AlgeriaDZA | HS 300420Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $31.6M | +2.7% | +0.3% |
| 20 | MoroccoMAR | HS 680291Marble, travertine and alabaster: articles thereof, (other than simply cut or sawn, with a flat or even surface) | $31.5M | +13.7% | +0.1% |
Sector opportunities
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 30
9 screened products with $2.0B of reported buyer imports.
$947.9MCalculated opportunity · +6.7% average growthHS2 39
3 screened products with $577.9M of reported buyer imports.
$295.0MCalculated opportunity · +8.6% average growthHS2 95
1 screened products with $119.9M of reported buyer imports.
$138.1MCalculated opportunity · +5.5% average growthHS2 87
2 screened products with $265.0M of reported buyer imports.
$127.8MCalculated opportunity · +8.5% average growthHS2 08
1 screened products with $214.8M of reported buyer imports.
$97.9MCalculated opportunity · +20.7% average growthHS2 52
1 screened products with $123.0M of reported buyer imports.
$67.1MCalculated opportunity · +8.4% average growthHS2 73
1 screened products with $228.4M of reported buyer imports.
$49.2MCalculated opportunity · +7.2% average growthHS2 15
1 screened products with $33.4M of reported buyer imports.
$46.8MCalculated opportunity · +18.9% average growthFrequently asked questions
Practical guidance for interpreting regional market and product comparisons.
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.